首页> 外文OA文献 >Cost-Effectiveness Of Roflumilast As Add-On To Triple Inhaled Therapy Versus Triple Inhaled Therapy In Patients With Severe And Very Severe Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis In The Netherlands

【2h】

Cost-Effectiveness Of Roflumilast As Add-On To Triple Inhaled Therapy Versus Triple Inhaled Therapy In Patients With Severe And Very Severe Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis In The Netherlands

机译：Roflumilast的成本效果作为三重吸入治疗与荷兰慢性支气管炎有关的严重和非常严重的慢性阻塞性肺病患者的三重吸入治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
A Miquel-Cases; A Berk; S Nekeman; M Bastiaanse; AA Sellink; S Ruiz;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. COST-EFFECTIVENESS OF ROFLUMILAST AS ADD-ON TO TRIPLE INHALED THERAPY VERSUS TRIPLE INHALED THERAPY IN PATIENTS WITH SEVERE AND VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASSOCIATED WITH CHRONIC BRONCHITIS IN THE UK [J] . Kiff C., Ruiz S., Varol N., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：Roflumilast的成本效益作为三重吸入治疗与三重吸入治疗患者患者严重和非常严重的慢性阻塞性肺病患者，英国慢性支气管炎
2. COST-EFFECTIVENESS OF ROFLUMILAST AS ADD-ON TO TRIPLE INHALED THERAPY VERSUS TRIPLE INHALED THERAPY IN PATIENTS WITH SEVERE AND VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASSOCIATED WITH CHRONIC BRONCHITIS IN THE UK [J] . Kiff C., Ruiz S., Varol N., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：Roflumilast的成本效益作为三重吸入治疗与三重吸入治疗患者患者严重和非常严重的慢性阻塞性肺病患者，英国慢性支气管炎
3. Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy versus triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK [J] . Chris Kiff, Sandrine Ruiz, Nebibe Varol, International Journal of Chronic Obstructive Pulmonary Disease . 2018,第1期

机译：罗氟司特作为重度和非常重度COPD合并慢性支气管炎患者的三重吸入疗法与三重吸入疗法的附加药物
4. An Automated Therapy Chair for Patients having Chronic Obstructive Pulmonary Disease (COPD) [C] . Md. Faizul Islam Chowdhury, S. M. Lutful Kabir, Sheikh Md. Rashedul Hasan IEEE International Conference on Biomedical Engineering, Computer and Information Technology for Health . 2019

机译：慢性阻塞性肺疾病（COPD）患者的自动治疗椅
5. Impact of Palliative Care on Patients with Severe Chronic Obstructive Pulmonary Disease [D] . Romero, Celena Therese. 2018

机译：姑息治疗对严重慢性阻塞性肺病患者的影响
6. Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy vs triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK [O] . Chris Kiff, Sandrine Ruiz, Nebibe Varol, 2018

机译：罗氟司特作为重度和非常重度慢性阻塞性肺病合并慢性支气管炎患者的三重吸入治疗与三重吸入治疗的附加药物
7. CE2 - COST-EFFECTIVENESS OF A NEW SINGLE INHALER TRIPLE THERAPY VERSUS A DUAL INHALED CORTICOSTEROID PLUS LONG-ACTING BETA AGONIST IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN [O] . N. Benjamin, A. Huerta, C. Biswas, 2018

机译：CE2 - 新的单一吸入器三重治疗的成本效益与双吸入的皮质类固醇加上西班牙慢性阻塞性肺病（COPD）患者的长效β激动剂

Cost-Effectiveness Of Roflumilast As Add-On To Triple Inhaled Therapy Versus Triple Inhaled Therapy In Patients With Severe And Very Severe Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis In The Netherlands

著录项

引文网络

相似文献

相关主题

期刊订阅